Viral meningoencephalitis: a focus on diagnostics
Por:
López, N, Cuesta, G and Puerta-Alcalde, P
Publicada:
1 dic 2025
Ahead of Print:
24 sep 2025
Resumen:
Purpose of reviewThis review provides an updated overview of diagnostic strategies for viral meningoencephalitis, with a focus on molecular techniques currently used in clinical practice and the emerging role of next-generation sequencing technologies.Recent findingsThe clinical and laboratory presentation of viral meningoencephalitis is often nonspecific, making timely and accurate diagnosis challenging. While PCR and multiplex RT-PCR assays have become widely used, they have notable limitations, including reduced sensitivity in low-viral-load cases and the requirement for prior pathogen suspicion. Newer platforms like QIAstat-Dx allow interpretation through cycle threshold values, but false positives and false negatives remain concerns. mNGS offers a hypothesis-free approach with improved diagnostic yield - especially in immunocompromised hosts and atypical presentations - and has proven valuable for detecting rare, emerging, or unexpected pathogens. However, practical limitations such as cost, long turnaround times, and the need for expert interpretation currently restrict its routine use.SummaryThe integration of mNGS into routine diagnostic workflows could significantly improve the diagnostic yield for viral meningoencephalitis, especially in cases with negative or inconclusive results from traditional methods. However, further studies are necessary to refine its clinical application, optimize cost-effectiveness, and establish guidelines for its use in the diagnostic management of meningoencephalitis.
Filiaciones:
López, N:
Hosp Clin Barcelona, Infect Dis Dept, Barcelona, Spain
Cuesta, G:
Serv Andorra Atencio Sanit, Microbiol Dept, Escaldes Engordany, Andorra
:
Hosp Badalona Germans Trias & Pujol, Infect Dis Dept, Carretera Canyet S-N, Badalona 08916, Spain
Fundacio Lluita Infecc, Badalona, Spain
Univ Vic UV, Univ Cent Catalunya, Vic, Spain
|